Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureAndrea Vincent Bonetti, Jacopo Giuliani
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The cost of cancer care in Europe 2018
10.1016/j.ejca.2020.01.011 · 2020
The high price of anticancer drugs: origins, implications, barriers, solutions
10.1038/nrclinonc.2017.31 · 2017
Prices and clinical benefit of cancerdrugs in the USA and Europe: a cost-benefit analysis
10.1016/s1470-2045(20)30139-x · 2020
Managed Entry Agreements for oncology drugs: lessons from the European Experience to inform the future
10.3389/fphar.2017.00171 · 2017
Innovation and drugs price and reimbursement: a comparison between Italy and the other major EU countries
10.5301/grhta.5000206 · 2015
The impact of managed entry agreement on pharmaceutical prices
10.1002/hec.4112 · 2020
10.1016/j.lanepe.2021.100050
10.1016/j.lanepe.2021.100050
Payers’ experiences with confidential pharmaceutical price discounts: a survey of public and statutory health systems in North America, Europe, and Australasia
10.1016/j.healthpol.2017.02.002 · 2017
10.12968/eqhe.2019.50.28
10.12968/eqhe.2019.50.28
Research and development spending to bring a single cancer drug to market and revenues after approval
Confidence 0%
10.1001/jamainternmed.2017.3601 · 2017
No additional external references are available.